JP2024516003A5 - - Google Patents
Info
- Publication number
- JP2024516003A5 JP2024516003A5 JP2023566803A JP2023566803A JP2024516003A5 JP 2024516003 A5 JP2024516003 A5 JP 2024516003A5 JP 2023566803 A JP2023566803 A JP 2023566803A JP 2023566803 A JP2023566803 A JP 2023566803A JP 2024516003 A5 JP2024516003 A5 JP 2024516003A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- therapeutic agent
- composition according
- patient
- diabetic retinopathy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163182037P | 2021-04-30 | 2021-04-30 | |
| US63/182,037 | 2021-04-30 | ||
| PCT/US2022/027062 WO2022232597A1 (en) | 2021-04-30 | 2022-04-29 | Methods and compositions for treatment of diabetic retinopathy and related conditions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024516003A JP2024516003A (ja) | 2024-04-11 |
| JP2024516003A5 true JP2024516003A5 (enExample) | 2025-05-09 |
Family
ID=83848745
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023566803A Pending JP2024516003A (ja) | 2021-04-30 | 2022-04-29 | 糖尿病網膜症および関連する状態を治療するための方法および組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240216315A1 (enExample) |
| EP (1) | EP4329741A4 (enExample) |
| JP (1) | JP2024516003A (enExample) |
| KR (1) | KR20240049212A (enExample) |
| CN (1) | CN117500492A (enExample) |
| AU (1) | AU2022264037A1 (enExample) |
| BR (1) | BR112023022561A2 (enExample) |
| CA (1) | CA3217136A1 (enExample) |
| IL (1) | IL308083A (enExample) |
| MX (1) | MX2023012793A (enExample) |
| WO (1) | WO2022232597A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2025529483A (ja) | 2022-09-14 | 2025-09-04 | オーパス・ジェネティクス・インコーポレイテッド | Ａｐｘ３３３０の塩及びエステルならびにその治療的使用 |
| WO2024158972A1 (en) * | 2023-01-25 | 2024-08-02 | Ocuphire Pharma, Inc. | Methods and compositions for preventing the progression of diabetic retinopathy and related conditions |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0817293A2 (pt) * | 2007-09-26 | 2015-06-16 | Univ Indiana Res & Tech Corp | Derivado de benzoquinona e3330 em combinação com agentes quimioterapêuticos para o tratamento de câncer e angiogenese |
| CA3090766A1 (en) * | 2018-02-08 | 2019-08-15 | Indiana University Research And Technology Corporation | Targeting ocular diseases with novel ape1/ref-1 inhibitors |
-
2022
- 2022-04-29 JP JP2023566803A patent/JP2024516003A/ja active Pending
- 2022-04-29 CA CA3217136A patent/CA3217136A1/en active Pending
- 2022-04-29 AU AU2022264037A patent/AU2022264037A1/en active Pending
- 2022-04-29 IL IL308083A patent/IL308083A/en unknown
- 2022-04-29 MX MX2023012793A patent/MX2023012793A/es unknown
- 2022-04-29 WO PCT/US2022/027062 patent/WO2022232597A1/en not_active Ceased
- 2022-04-29 US US18/288,435 patent/US20240216315A1/en active Pending
- 2022-04-29 EP EP22796862.5A patent/EP4329741A4/en active Pending
- 2022-04-29 BR BR112023022561A patent/BR112023022561A2/pt unknown
- 2022-04-29 KR KR1020237041163A patent/KR20240049212A/ko active Pending
- 2022-04-29 CN CN202280038694.0A patent/CN117500492A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102382077B1 (ko) | 우르소데옥시콜산을 함유하는 시각장애 예방 또는 치료용 조성물 | |
| JP2025169389A5 (enExample) | ||
| TWI250016B (en) | Use of pramipexole for the treatment of addictive disorders | |
| JP5212849B2 (ja) | 眼内血管新生及び／又は眼内血管透過性亢進を伴う疾患の予防又は治療のための医薬 | |
| JP6353577B2 (ja) | 組み合わせ組成物 | |
| JPH0222229A (ja) | 神経細胞及び神経繊維の疾患もしくは傷害の治療に用いる組み合わせ調合剤 | |
| US20130317036A1 (en) | Folic acid - ramipril combination: cellprotective, neuroprotective and retinoprotective ophtalmologic compositions | |
| Ishibashi | Oral ketoconazole therapy for keratomycosis | |
| JP2023154024A (ja) | 眼病態を治療するための方法および組成物 | |
| JP2022533968A5 (enExample) | ||
| EP4520394A3 (en) | New therapeutic combinations for the treatment of progressive fibrosing interstitial lung diseases | |
| AU2024356340A1 (en) | N-n-dimethyltryptamine (dmt) and dmt analog oral transmucosal film compositions, methods of making, and methods of use thereof | |
| JP2015523986A5 (enExample) | ||
| JP2023548429A5 (enExample) | ||
| RU2006124557A (ru) | Композиции и способы введения средств, связывающих тубулин, для лечения глазных заболеваний | |
| JP2019507786A5 (enExample) | ||
| CZ181193A3 (en) | Pharmaceutical preparation in the form of a solution for local administration in eye, the use and preparation method thereof | |
| JP2024545496A5 (enExample) | ||
| JP2004091473A (ja) | 色素沈着改善治療薬 | |
| WO2010117077A1 (ja) | シロリムス誘導体を有効成分として含有する網脈絡膜疾患の治療剤 | |
| JP2021138710A5 (enExample) | ||
| SCHEIE et al. | Treatment of herpes zoster ophthalmicus with cortisone or corticotropin | |
| Noguchi et al. | Case report. Sporotrichosis successfully treated with itraconazole in Japan | |
| US20190224208A1 (en) | Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation | |
| JP2024530344A5 (enExample) |